Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
China - Hong Kong SAR 1996-2001347481.365.757.885.776.975.575.981.2
China - Qidong 1992-200036651.538.732.954.345.342.942.147.3
China - Shangai 1992-1995175071.956.851.175.465.064.362.974.5
China - Tianjin 1991-1999202076.663.959.680.273.074.673.481.1
Cuba 1994-199581974.859.053.377.565.563.864.168.8
India - Bhopal 1991-19954654.317.46.557.119.67.86.09.7
India - Chennai 1990-199944258.230.723.261.235.729.825.732.0
India - Karunagappally 1991-19973865.337.934.669.045.046.444.548.4
India - Mumbai 1992-1994130767.045.632.570.653.641.834.645.6
Singapore 1993-199749676.658.951.880.267.064.062.771.9
Republic of Korea - Busan 1996-200199983.468.960.185.975.169.362.272.8
Republic of Korea - Incheon 1997-200146778.065.560.180.772.171.065.976.1
Republic of Korea - Seoul 1993-1997193085.570.764.288.377.975.770.979.5
Thailand - Chiang Mai 1993-199722360.339.528.861.141.130.726.533.2
Thailand - Khon Kaen 1993-199710376.359.659.677.361.963.867.359.7
Thailand - Lampang 1990-200026567.248.742.868.251.146.646.949.5
Thailand - Songkhla 1990-199915580.958.841.482.362.045.545.645.9
Turkey - Izmir 1995-199756684.767.357.787.775.169.769.970.7



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period